fda semaglutide alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Hims & Hers stock falls
Description
Short-acting GLP-1 RAs (e.g., exenatide, lixisenatide) were found to have a reduced impact on overnight and fasting blood glucose levels, while long-acting GLP-1 RAs (liraglutide, exenatide once weekly, dulaglutide, and semaglutide) were found to have an increased effect and better coverage on overnight and fasting blood glucose and HbA1c levels [18]
The FDA states that compounded drugs are "not reviewed by FDA prior to marketing and are not FDA-approved." What this means for consumers: When accessing compounded semaglutide or tirzepatide through telehealth platforms, you are receiving a medication that contains the same active ingredient as FDA-approved products but is prepared differently and has not undergone FDA approval as a finished product
Poor dietary habits, fuelled by food noise, can negatively affect the balance of bacteria in our gut
10.1210/jc.2015-2335 109
European Association for the Study of Obesity (EASO)
